Rejuve.Bio Launches Groundbreaking Crowd Fund on NetCapital to Pioneer the Future of Artificial General Intelligence and Longevity

Embark on a journey to redefine aging with cutting-edge biotech innovation. LOS ANGELES, March 12, 2024 /PRNewswire/ — Rejuve.Bio, a leading AI biotechnology firm at the forefront of the longevity revolution, announces its latest initiative: a Crowd Fundraise on the NetCapital platform….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks